NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Virtual Investor Forum to be held September 19th. This event is co-sponsored by Zacks Small-Cap Research
Individual investors, institutional investors, advisors, and analysts are invited to attend.
REGISTER NOW AT: https://bit.ly/3XnsBlt
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations, or schedule 1x1 meetings with management.
“We’re looking forward to bringing the latest innovators together at the Life Sciences Virtual Investor Forum this Thursday,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. “In collaboration with Zacks Small-Cap Research, this conference will provide an efficient platform for these companies to seamlessly engage their investor base.”
September 19th
| Eastern Time (ET) | Presentation | Ticker(s) |
| 9:30 AM | VolitionRX Limited | NYSE American: VNRX |
| 10:00 AM | Genflow Biosciences Plc | OTCQB: GENFF | LSE: GENF |
| 10:30 AM | Aprea Therapeutics, Inc. | Nasdaq: APRE |
| 11:00 AM | Chromocell Therapeutics Corp. | NYSE American: CHRO |
| 11:30 AM | BioVaxys Technology Corp. | OTCQB: BVAXF | CSE: BIOV |
| 12:00 PM | Protalix BioTherapeutics, Inc. | NYSE American: PLX |
| 12:30 PM | Acasti Pharma Inc. | Nasdaq: ACST |
| 1:00 PM | Brainstorm Cell Therapeutics Inc. | Nasdaq: BCLI |
| 1:30 PM | Aethlon Medical, Inc. | Nasdaq: AEMD |
| 2:00 PM | Unicycive Therapeutics, Inc. | Nasdaq: UNCY |
| 2:30 PM | Evaxion Biotech A/S | Nasdaq: EVAX |
| 3:00 PM | Adaptimmune Therapeutics plc | Nasdaq: ADAP |
To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
Media Contact:
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com
Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com
